glp-1 drugs covered by medicaid Few state programs cover GLP-1s for obesity: KFF Medicare, Medicaid will cover GLP-1

In June 2026, the FDA updated the OTC weight loss drug alli (orlistat) label to include a warning about the rare risk of kidney stones and acute kidney injury

Each treatment is administered by trained professionals in a comfortable clinical setting

Refrigeration slows these reactions down dramatically, extending the peptide's useful life from a few days to several weeks or even months, depending on the concentration and handling

"Lipid Peroxidation"

About one in seven adults who have ever used GLP-1 medications say they are no longer using these drugs because of the cost (14%), similar to the share who report no longer taking the medications because of side effects (13%)

doi: 10.1186/s12987-021-00283-y 16 FennemaD.PhillipsI